Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 11 Comparison of different dose exposures

From: Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer

Comparison of different dose exposures in μSv/h

in the distance

1 m from the patient

2 m from the patient

3 h after application of Technetium-99 m-labeled pharmaceuticals used in the skeletal scintigraphy

5.4–13.4

not measured

30 min after Radium-223 application

0.376–0.504

0.183–0.205

background in corridors and offices

0.101–0.141

  1. μSv/h – microsievert/hour
  2. Source: Own processing
Back to article page

Health Economics Review

ISSN: 2191-1991

Contact us